We want to help kidney cancer researchers locate funding opportunities. We’ll update this page with grant opportunities as we learn about them. Know of one we haven’t listed? Email us at [email protected], or tweet at us, and we’ll get it posted!
KidneyCAN is dedicated to accelerating kidney cancer research.
Our advocacy for the DoD Kidney Cancer Research Program resulted in appropriations of $50 million in fiscal year 2022 for kidney cancer research, bring the 2017-2022 total to $185 million. In 2016, this number was $0.
Our Kidney Cancer Research Summit brings translational researchers in kidney cancer together in an annual collaborative meeting.
Additionally, KidneyCAN’s “Rock the Cure” events have raised over $1,000,000 toward private research support.
Please share this notice with other researchers in your network.
- Develop your ideas
- Build your team – even including members from other institutions
- Gather letters of support
- Review the grant mechanisms (including the new ones) and consider which would best support your idea
- Consider partnerships (including industry partnerships) and collaborations
FY21 KCRP Program Announcements Released
As new announcements are posted, we will keep you updated.
AACR: New Funding Opportunities
We’d love to see more RCC applicants for these prestigious grant opportunities.
KidneyCAN is proud to present the 4th annual Kidney Cancer Research Summit on October 6-7, 2022. KCRS is a meeting focused on basic, translational, and clinical kidney cancer research. This meeting is fueled by the ideas and research funded through the Department of Defense CDMRP-KCRP awards.
The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.
Kidney cancer is the ideal sandbox for these new approaches, and without a doubt the same approach can, should and will be suitable for other cancers.
Dr. Hans Hammers, UTSW
On August 8-9th, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event...
Brandon Manley, M.D., is a urologic oncologist who specializes in genitourinary oncology, with a focus on patients with kidney cancer. He currently practices at Moffitt Cancer Center in Tampa, Florida, where he lives with his wife Aimee, and his two daughters Sadie...
The International Kidney Cancer Coalition launched a pilot program to understand the barriers and other considerations that drive the decision to leave a clinical trial and uncover ways to better support patients currently in or considering joining clinical trials....